MARKET WIRE NEWS

Replimune Group, Inc. (REPL) Q4 2025 Earnings Call Transcript

Source: SeekingAlpha

2025-05-22 11:19:05 ET

Replimune Group, Inc. (REPL)

Q4 2025 Results Conference Call

May 22, 2025 08:00 AM ET

Company Participants

Arleen Goldenberg - Senior Communications Leader

Sushil Patel - Chief Executive Officer

Chris Sarchi - Chief Commercial Officer

Emily Hill - Chief Financial Officer

Conference Call Participants

Anupam Rama - J.P. Morgan

Roger Song - Jefferies

Jonathan Chang - Leerink

Allison Bratzel - Piper Sandler

Peter Lawson - Barclays

Presentation

Operator

Good morning and welcome to the Replimune Fiscal Year Fourth Quarter 2025 Financial Results and Corporate Update Conference Call. Currently, all participants are in listen-only mode. This call is being webcast live on the investors and media section of Replimune's website at replimune.com, and a recording will be available after the call.

I would like to introduce Arleen Goldenberg from Replimune. Please go ahead.

Arleen Goldenberg

Thank you, Operator, and good morning, everyone. Thank you for joining us today for a discussion of Replimune's fiscal year fourth quarter 2025 business highlights and financial results. ...

Read the full article on Seeking Alpha

For further details see:

Replimune Group, Inc. (REPL) Q4 2025 Earnings Call Transcript
Replimune Group Inc.

NASDAQ: REPL

REPL Trading

-10.42% G/L:

$4.6493 Last:

4,448,331 Volume:

$5.06 Open:

mwn-alerts Ad 300

REPL Latest News

April 23, 2026 01:35:20 pm
TRT for Massive Gains

REPL Stock Data

$646,543,607
51,607,887
0.33%
61
N/A
Biotechnology & Life Sciences
Healthcare
US
Woburn

Subscribe to Our Newsletter

Link Market Wire News to Your X Account

Download The Market Wire News App